SURVODUTIDE

Glucagon/GLP-1 receptor co-agonist research compound associated with metabolic and liver-related pathway studies.

Use

Intended exclusively for in vitro research or compliant laboratory use under applicable regulations; not for human use.

Purpose

Research on energy metabolism, lipid handling, appetite regulation, body composition, and hepatic metabolic models.